Tg Therapeutics (TGTX) Assets (2010 - 2026)

Tg Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Assets rose 132.81% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 132.81% YoY), while the FY2025 annual figure was $1.1 billion, up 84.05% from the prior year.
• Assets was $1.5 billion for Q1 2026 at Tg Therapeutics, up from $1.1 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $1.5 billion in Q1 2026 to a low of $193.6 million in Q4 2022.
• Historically, Assets has averaged $527.0 million across 5 years, with a median of $373.3 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Assets sank 49.01% in 2022, then surged 132.81% in 2026.
• A 5-year view of Assets shows it stood at $193.6 million in 2022, then soared by 70.27% to $329.6 million in 2023, then soared by 75.28% to $577.7 million in 2024, then surged by 84.05% to $1.1 billion in 2025, then jumped by 43.79% to $1.5 billion in 2026.
• The last three Assets figures came in at $1.5 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.